Latest Affinity Asset Advisors, LLC Stock Portfolio
$807Million
Equity Portfolio Value
Last Reported on: 14 May, 2024
About Affinity Asset Advisors, LLC and it’s 13F Hedge Fund Stock Holdings
Affinity Asset Advisors, LLC is a hedge fund based in NEW YORK, NY. On 29-Mar-2023, the fund reported that it had an AUM (Regulated Assets under Management) of $237.6 Millions. In it's latest 13F Holdings report, Affinity Asset Advisors, LLC reported an equity portfolio of $807.8 Millions as of 31 Mar, 2024.
The top stock holdings of Affinity Asset Advisors, LLC are , XENE, MDGL. The fund has invested 4.9% of it's portfolio in APOGEE THERAPEUTICS INC and 4.5% of portfolio in XENON PHARMACEUTICALS INC.
The fund managers got completely rid off IMMUNOGEN INC (IMGN), CYMABAY THERAPEUTICS INC (CBAY) and LIANBIO (LIAN) stocks. They significantly reduced their stock positions in VIKING THERAPEUTICS INC (VKTX), ALKERMES PLC (ALKS) and CEREVEL THERAPEUTICS HLDNG I (CERE). Affinity Asset Advisors, LLC opened new stock positions in VERA THERAPEUTICS INC (VERA), BEIGENE LTD (BGNE) and GERON CORP (GERN). The fund showed a lot of confidence in some stocks as they added substantially to INARI MED INC (NARI), TERNS PHARMACEUTICALS INC (TERN) and MORPHIC HLDG INC (MORF).
The top stock holdings of Affinity Asset Advisors, LLC are , XENE, MDGL. The fund has invested 4.9% of it's portfolio in APOGEE THERAPEUTICS INC and 4.5% of portfolio in XENON PHARMACEUTICALS INC.
The fund managers got completely rid off IMMUNOGEN INC (IMGN), CYMABAY THERAPEUTICS INC (CBAY) and LIANBIO (LIAN) stocks. They significantly reduced their stock positions in VIKING THERAPEUTICS INC (VKTX), ALKERMES PLC (ALKS) and CEREVEL THERAPEUTICS HLDNG I (CERE). Affinity Asset Advisors, LLC opened new stock positions in VERA THERAPEUTICS INC (VERA), BEIGENE LTD (BGNE) and GERON CORP (GERN). The fund showed a lot of confidence in some stocks as they added substantially to INARI MED INC (NARI), TERNS PHARMACEUTICALS INC (TERN) and MORPHIC HLDG INC (MORF).
New Buys
| Ticker | $ Bought |
|---|---|
| VERA THERAPEUTICS INC | 20,266,400 |
| BEIGENE LTD | 12,846,300 |
| ALNYLAM PHARMACEUTICALS INC | 9,448,760 |
| GERON CORP | 8,250,000 |
| ELEVATION ONCOLOGY INC | 6,509,070 |
| PERSPECTIVE THERAPEUTICS INC | 6,069,000 |
| ABSCI CORPORATION | 5,822,000 |
| MINERALYS THERAPEUTICS INC | 4,233,950 |
New stocks bought by Affinity Asset Advisors, LLC
Additions
Additions to existing portfolio by Affinity Asset Advisors, LLC
Reductions
| Ticker | % Reduced |
|---|---|
| VIKING THERAPEUTICS INC | -83.33 |
| ALKERMES PLC | -78.96 |
| CEREVEL THERAPEUTICS HLDNG I | -60.00 |
| CYTOKINETICS INC | -50.00 |
| TANGO THERAPEUTICS INC | -49.95 |
| ASTRIA THERAPEUTICS INC | -42.34 |
| BRIDGEBIO PHARMA INC | -37.5 |
| ESTABLISHMENT LABS HLDGS INC | -27.9 |
Affinity Asset Advisors, LLC reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| LIANBIO | -16,895,200 |
| IMMUNOGEN INC | -41,646,600 |
| CYMABAY THERAPEUTICS INC | -25,756,200 |
| ADC THERAPEUTICS SA | -1,682,480 |
| ALLOGENE THERAPEUTICS INC | -1,284,000 |
| ARAVIVE INC | -42,863 |
| DYNAVAX TECHNOLOGIES CORP | -4,194,000 |
| RELAY THERAPEUTICS INC | -3,303,000 |
Affinity Asset Advisors, LLC got rid off the above stocks
Current Stock Holdings of Affinity Asset Advisors, LLC
Last Reported on: 14 May, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options |
|---|---|---|---|---|---|---|---|
| ABSI | ABSCI CORPORATION | 0.72 | 1,025,000 | 5,822,000 | NEW | ||
| ACLX | ARCELLX INC | 2.58 | 300,000 | 20,865,000 | REDUCED | -11.76 | |
| ADCT | ADC THERAPEUTICS SA | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| AGLE | SPYRE THERAPEUTICS INC | 1.93 | 410,000 | 15,551,300 | REDUCED | -20.78 | |
| ALKS | ALKERMES PLC | 0.25 | 75,000 | 2,030,250 | REDUCED | -78.96 | |
| ALLO | ALLOGENE THERAPEUTICS INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| ALNY | ALNYLAM PHARMACEUTICALS INC | 1.17 | 10,000,000 | 9,448,760 | NEW | ||
| APLS | APELLIS PHARMACEUTICALS INC | 1.20 | 165,000 | 9,698,700 | ADDED | 120 | |
| ARAV | ARAVIVE INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| ARGX | ARGENX SE | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| ARWR | ARROWHEAD PHARMACEUTICALS IN | 0.42 | 120,000 | 3,432,000 | NEW | ||
| ARYD | ARYA SCIENCES ACQU CORP IV | 0.19 | 133,500 | 1,504,540 | NEW | ||
| ASND | ASCENDIS PHARMA A/S | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| ATXS | ASTRIA THERAPEUTICS INC | 1.47 | 845,606 | 11,901,900 | REDUCED | -42.34 | |
| AUTL | AUTOLUS THERAPEUTICS PLC | 2.67 | 3,375,000 | 21,532,500 | ADDED | 117 | |
| AVRO | AVROBIO INC | 0.11 | 700,000 | 896,000 | ADDED | 40.00 | |
| AVTX | AVALO THERAPEUTICS INC | 0.03 | 10,000 | 217,500 | NEW | ||
| AXSM | AXSOME THERAPEUTICS INC | 1.38 | 139,758 | 11,152,700 | ADDED | 179 | |
| AZN | ASTRAZENECA PLC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| BBIO | BRIDGEBIO PHARMA INC | 2.27 | 17,000,000 | 18,298,300 | UNCHANGED | 0.00 | |
| BBIO | BRIDGEBIO PHARMA INC | 0.19 | 50,000 | 1,546,000 | REDUCED | -37.5 | |
| BGNE | BEIGENE LTD | 1.59 | 82,143 | 12,846,300 | NEW | ||
| BSX | BOSTON SCIENTIFIC CORP | 0.21 | 25,000 | 1,712,250 | NEW | ||
| CBAY | CYMABAY THERAPEUTICS INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| CERE | CEREVEL THERAPEUTICS HLDNG I | 1.57 | 300,000 | 12,681,000 | REDUCED | -60.00 | |
| CGEM | CULLINAN ONCOLOGY INC | 0.54 | 258,588 | 4,406,340 | REDUCED | -13.8 | |
| CHRS | COHERUS BIOSCIENCES INC | 0.72 | 9,000,000 | 5,784,790 | ADDED | 50.00 | |
| CLDX | CELLDEX THERAPEUTICS INC NEW | 2.65 | 510,000 | 21,404,700 | ADDED | 27.5 | |
| CMPS | COMPASS PATHWAYS PLC | 1.06 | 1,027,870 | 8,551,860 | ADDED | 86.89 | |
| CNTA | CENTESSA PHARMACEUTICALS PLC | 1.16 | 830,546 | 9,385,170 | ADDED | 4.38 | |
| CNTX | CONTEXT THERAPEUTICS INC | 0.06 | 328,817 | 453,767 | UNCHANGED | 0.00 | |
| CRNX | CRINETICS PHARMACEUTICALS IN | 2.72 | 470,000 | 22,000,700 | ADDED | 5.12 | |
| CYTK | CYTOKINETICS INC | 0.69 | 80,000 | 5,608,800 | REDUCED | -50.00 | |
| DVAX | DYNAVAX TECHNOLOGIES CORP | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| ELEV | ELEVATION ONCOLOGY INC | 0.81 | 1,268,820 | 6,509,070 | NEW | ||
| ESTA | ESTABLISHMENT LABS HLDGS INC | 1.04 | 164,589 | 8,377,580 | REDUCED | -27.9 | |
| EYPT | EYEPOINT PHARMACEUTICALS INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| FULC | FULCRUM THERAPEUTICS INC | 0.64 | 550,339 | 5,195,200 | ADDED | 340 | |
| GERN | GERON CORP | 1.02 | 2,500,000 | 8,250,000 | NEW | ||
| IFRX | INFLARX NV | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| IMGN | IMMUNOGEN INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| IMTX | IMMATICS N.V | 0.46 | 350,000 | 3,678,500 | ADDED | 75.00 | |
| IMTX | IMMATICS N.V | 0.06 | 187,204 | 486,730 | UNCHANGED | 0.00 | |
| IMVT | IMMUNOVANT INC | 1.14 | 285,000 | 9,208,350 | REDUCED | -17.39 | |
| INZY | INOZYME PHARMA INC | 2.51 | 2,642,520 | 20,241,700 | ADDED | 40.13 | |
| ITCI | INTRA-CELLULAR THERAPIES INC | 0.43 | 50,000 | 3,460,000 | NEW | ||
| KALV | KALVISTA PHARMACEUTICALS INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| KRYS | KRYSTAL BIOTECH INC | 0.59 | 26,746 | 4,758,920 | ADDED | 6.98 | |
| KURA | KURA ONCOLOGY INC | 1.93 | 730,492 | 15,581,400 | ADDED | 281 | |
| KZR | KEZAR LIFE SCIENCES INC | 0.20 | 1,761,780 | 1,588,420 | NEW | ||
| LIAN | LIANBIO | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| MDGL | MADRIGAL PHARMACEUTICALS INC | 3.80 | 115,000 | 30,709,600 | ADDED | 15.00 | |
| MIRM | MIRUM PHARMACEUTICALS INC | 0.50 | 160,000 | 4,019,200 | ADDED | 220 | |
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 0.47 | 75,000 | 3,767,250 | ADDED | 5.65 | |
| MORF | MORPHIC HLDG INC | 0.98 | 225,000 | 7,920,000 | ADDED | 427 | |
| MRSN | MERSANA THERAPEUTICS INC | 0.56 | 1,000,000 | 4,480,000 | UNCHANGED | 0.00 | |
| MRTX | MIRATI THERAPEUTICS INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| NAMS | NEWAMSTERDAM PHARMA COMPANY | 0.84 | 286,200 | 6,768,630 | ADDED | 128 | |
| NAMS | NEWAMSTERDAM PHARMA COMPANY | 0.28 | 202,599 | 2,236,690 | ADDED | 47.88 | |
| NARI | INARI MED INC | 1.04 | 175,000 | 8,396,500 | ADDED | 775 | |
| NBIX | NEUROCRINE BIOSCIENCES INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| NRIX | NURIX THERAPEUTICS INC | 1.48 | 810,253 | 11,910,700 | ADDED | 17.41 | |
| NUVB | NUVATION BIO INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| NUVL | NUVALENT INC | 1.39 | 150,000 | 11,263,500 | REDUCED | -14.29 | |
| NXTC | NEXTCURE INC | 0.38 | 1,359,040 | 3,030,650 | NEW | ||
| OMER | OMEROS CORP | 0.94 | 10,500,000 | 7,632,450 | ADDED | 75.00 | |
| PASG | PASSAGE BIO INC | 0.04 | 264,266 | 356,759 | NEW | ||
| PBYI | PUMA BIOTECHNOLOGY INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| PCVX | VAXCYTE INC | 0.68 | 80,000 | 5,464,800 | ADDED | 220 | |
| PEN | PENUMBRA INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| PMN | PROMIS NEUROSCIENCES INC | 0.06 | 265,958 | 507,980 | UNCHANGED | 0.00 | |
| PTGX | PROTAGONIST THERAPEUTICS INC | 0.36 | 100,000 | 2,893,000 | NEW | ||
| RCKT | ROCKET PHARMACEUTICALS INC | 0.00 | 75,000 | 22,440 | UNCHANGED | 0.00 | |
| RGNX | REGENXBIO INC | 0.29 | 110,000 | 2,317,700 | NEW | ||
| RLAY | RELAY THERAPEUTICS INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| ROIV | ROIVANT SCIENCES LTD | 0.65 | 500,000 | 5,270,000 | UNCHANGED | 0.00 | |
| RZLT | REZOLUTE INC | 0.50 | 1,600,000 | 4,080,000 | NEW | ||
| SAVA | CASSAVA SCIENCES INC | 0.01 | 24,200 | 97,524 | NEW | ||
| SVRA | SAVARA INC | 0.71 | 1,150,000 | 5,727,000 | UNCHANGED | 0.00 | |
| SWTX | SPRINGWORKS THERAPEUTICS INC | 0.61 | 100,000 | 4,922,000 | UNCHANGED | 0.00 | |
| TERN | TERNS PHARMACEUTICALS INC | 0.36 | 450,000 | 2,952,000 | ADDED | 581 | |
| TEVA | TEVA PHARMACEUTICAL INDS LTD | 2.45 | 1,400,000 | 19,754,000 | REDUCED | -26.32 | |
| TNGX | TANGO THERAPEUTICS INC | 0.15 | 150,274 | 1,193,180 | REDUCED | -49.95 | |
| TVTX | TRAVERE THERAPEUTICS INC | 0.12 | 125,000 | 963,750 | NEW | ||
| VERA | VERA THERAPEUTICS INC | 2.51 | 470,000 | 20,266,400 | NEW | ||
| VKTX | VIKING THERAPEUTICS INC | 0.51 | 50,000 | 4,100,000 | REDUCED | -83.33 | |
| VRDN | VIRIDIAN THERAPEUTICS INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| VRNA | VERONA PHARMA PLC | 1.63 | 817,833 | 13,158,900 | ADDED | 45.05 | |
| WVE | WAVE LIFE SCIENCES LTD | 0.22 | 286,585 | 1,768,230 | NEW | ||
| XENE | XENON PHARMACEUTICALS INC | 4.46 | 837,387 | 36,049,500 | ADDED | 82.04 | |
| APOGEE THERAPEUTICS INC | 4.87 | 592,093 | 39,344,600 | ADDED | 10.24 | ||
| PERSPECTIVE THERAPEUTICS INC | 0.75 | 5,100,000 | 6,069,000 | NEW | |||
| MINERALYS THERAPEUTICS INC | 0.52 | 327,959 | 4,233,950 | NEW | |||
| HELIX ACQUISITION CORP II | 0.32 | 250,000 | 2,587,500 | NEW | |||
| ZURA BIO LTD | 0.14 | 450,009 | 1,156,520 | NEW | |||
| TOURMALINE BIO INC | 0.14 | 50,000 | 1,145,000 | REDUCED | -26.56 | ||
| Q32 BIO INC | 0.06 | 27,777 | 473,320 | NEW | |||
| BIOHAVEN LTD | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 |